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Aspirin renography to detect unilateral renovascular
hypertension
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Renal arteriography has been the "gold standard" for detec-
tion of renal arterial stenosis. However, it is invasive and costly
and does not detect physiologic abnormalities used to differen-
tiate incidental renal arterial stenosis from renovascular hyper-
tension. As a noninvasive screening method for renovascular
hypertension, radionuclide renograms are widely used, but
their sensitivity and specificity are unsatisfactory [1—3]. For
increased sensitivity and specificity in the detection of renovas-
cular hypertension, renograms taken after the administration of
captopril, an inhibitor of angiotensin converting enzyme, have
been tried [1—6]. The rationale for the test is that the renin-
angiotensin system is involved in the autoregulation of the
glomerular filtration rate [1, 3, 4]. The tracer most suitable for
this test is technetium-99m diethylenetriaminepentaacetic acid
(99mTc..DTpA) [2, 4, 5]. However, iodine-123-orthoiodohippu-
rate (['231]OIH) is used more often for first renographic exam-
inations, because it is excreted from the kidneys more quickly
than DTPA and because it gives information about overall renal
function [2]. As changes in the OIH value reflect the renal blood
flow, renography with ['231]OIH cannot uncover renal arterial
stenosis that causes hypertension without much decreasing the
renal blood flow.
Prostaglandin (PG) acts as a vasodilator to maintain the renal
blood flow, especially when renal artery stenosis is at the
borderline for autoregulation of blood flow [7—9]. In subjects
with unilateral renovascular hypertension, synthesis of PGE2 is
increased in the stenotic kidney, and the PG is important
pathophysiologically in accelerating renin release [10]. Inhibi-
tion of renal PG synthesis might be useful in renography with
[1231]OIH, giving more sensitive detection of renal arterial
stenosis that causes hypertension. Here, we studied nine pa-
tients with or without unilateral renal arterial stenosis. We tried
renography done in combination with aspirin administration,
and suggest that such renography may be a new noninvasive
and sensitive method to detect renovascular hypertension.
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Methods
We studied eight patients with unilateral renal arterial steno-
sis of various degrees (from 45% in diameter to more than 90%)
and one patient (patient 1) without stenosis. Profiles of the
patients are given in Table 1. Patient 1 (a control patient)
underwent various examinations and was diagnosed as having
essential hypertension. His renal arteries were without stenosis
as seen by Doppler ultrasonography. The degree of renal
arterial stenosis in patient 2, the other control, was 45% (mild).
The degree of stenosis in patients 3 to 6 was 50 to 75%of the
vessel diameter (moderate) and that in patients 7 to 9 was more
than 75% (severe), as assessed by digital subtraction angiogra-
phy. Angiography was done after an arterial injection of con-
trast medium, and the angiograms, which were magnified
views, were examined by two radiologists and one physician. In
the outpatient clinic, patient 2 was found to have mild hyper-
tension, with onset within the preceding two years. An exami-
nation by color Doppler ultrasonography and measurement of
the velocity of renal arterial blood flow showed renal arterial
stenosis. However, renovascular hypertension was ruled out:
blood pressure became normal after the patient was admitted to
the hospital, and the renin ratio of the renal veins did not satisfy
the diagnostic criteria for renovascular hypertension (Table 4).
In addition, percutaneous transluminal renal arterial angio-
plasty (performed at the patient's request after this study)
decreased the stenotic degree to less than 25% of vessel
diameter, but the blood pressure was unchanged. Patients 4 and
6 had abdominal aortic aneurysms (infrarenal), patient 5 had
arteriosclerotic obliterance, and patient 7 had a dissecting
aneurysm of the aorta (DeBakey type Ilib). Patients 3 to 9 were
already receiving medication at the time of entry to this study,
and the medication could not be withdrawn. The kind of
medication and the dosages were not changed during the study.
After the study ended, patients 3, 8, and 9 also underwent
percutaneous transluminal renal arterial angioplasty, and pa-
tients 4 and 6 had aorto-renal arterial bypass surgery at the
same time as an operation for the abdominal aortic aneurysm.
The responses of blood pressure to the revascularization were
monitored for at least one year, and their hypertension was
much improved or became normal after the operations. Blood
pressure became normal in patient 4 (who could stop the
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Table 1. Patient profiles
Patient Age/sex
Stenotic
side/%
stenosis
UN/creatinine
mg/dl/mg/dl
Duration of
hypertension
years
Antihypertensive
medication
1 (non-RVH) 45/M — 12/0.8 >4 None
without renal
arterial stenosis
2 (non-RVH) 39/M R/45 11/0.7 2 None
3 (RVH) 50/M L/60 15/0.8 7 Nifedipine 40 mg/day
4 (RVH) 59/M L/70 13/0.7 unknown Nifedipine 80 mg/day
5 (RVH) 55/M L/75 16/0.9 3 Nifedipine 40 mg/day
6 (RVH) 71/F L/75 12/0.7 5 Nilvadipine 8 mg/day
7 (RVH) 56/M L/>75 20/1.1 >18 Nifedipine 80 mg/day
8 (RVH) 48/F L/90 28/1.4 17 Nifedipine 80 mg/day
9 (RVH) 72/F L/>90 18/1.1 >11 Nifedipine 40 mg/day
Atenolol 25 mg/day
Guanabenz 4 mg/day
Abbreviations are: UN, levels of serum urea nitrogen; creatinine, creatinine levels in serum; % stenosis, percent stenosis of renal artery in terms
of diameter; RVH, renovascular hypertension; M, male; F, female; R, right renal artery; L, left renal artery.
medication) and in patient 8 (who continued the same medica-
tion as before the operation). Blood pressure controlled by
medication before the operation was maintained without med-
ication or with decreased medication after the operation in
patients 3, 6, and 9 ("pre-operative blood pressure" in Table 3).
In these patients (3, 4, 6, 8, and 9), renovascular hypertension
was diagnosed by the criteria of the Cooperative Study of
Renovascular Hypertension. Patient 5 refused invasive ther-
apy, and angioplasty was not indicated for patient 7 with aortic
dissection (instead, the patient was scheduled for surgery). The
diagnosis of renovascular hypertension was made on the basis
of results of the captopril test, the renal vein renin ratio, or
both. Starting at least one week before and lasting throughout
the study, the meals provided for the patients contained approx-
imately 120 mEq of sodium daily.
Radionuclide renography was done three times for each
patient (except patients 1, 5, and 8), with a maximum of one
week between consecutive tests. The first test was the baseline
study. After oral administration of water (250 ml), the tracer,
[1231]OIH (37 MBq), was injected intravenously and renal
scintigraphy was done with a digital gamma camera (Starcam
400 AC/T, General Electric, Milwaukee, Minnesota, USA)
interfaced with a computer, which generated renogram curves.
A sequence of dynamic images was acquired in the posterior
view with the patient lying supine over the collimator. The
second renography was done one hour after the oral adminis-
tration of aspirin (20 mg/kg), an inhibitor of PG synthesis. The
third renography was done one hour after the oral administra-
tion of captopril (50 mg). In patients 1, 5, and 8, captopril
renography could not be done. Data obtained by renography
were stored in eighty 15-second frames of a 64 x 64 cell matrix.
Regions of interest for the kidneys were traced once for each
patient and used for all three studies of the same patient. The
time-activity curves for each kidney were plotted after subtrac-
tion of the activity in the renal pelvis from that in the renal
parenchyma (regions of interest were drawn to exclude the
renal pelvis on the cumulative images). As an indication of the
extent of renal arterial stenosis (decrease in renal blood flow),
the time to the maximum peak of the renogram curve was
assessed. We refer to a decrease in renal blood flow as being
significant if the time to the peak in the renogram was five
minutes or more [5, 11, 12], and defined the difference in the
peak times of the two kidneys as significant when it was two
minutes or more. During the second and third studies, blood
pressure in the right upper arm and the heart rate were
measured every five minutes for about 1.5 hours with an
automatic ultrasound sphygmomanometer (BP-103, Nippon
Cohn Co., Komaki City, Aichi Prefecture, Japan). The data for
systolic and diastolic blood pressures immediately before (four
measurements) and at about one hour after (four measure-
ments) the drug administration were compared by Student's
i-test. These results are expressed as means SEM.
Before injection of contrast medium during digital subtraction
angiography, blood was sampled in patients 2 to 4 and 7 to 9.
Thirty minutes after catheterization of the right femoral artery
and vein by Seldinger's method, abdominal aortic and bilateral
renal venous blood was sampled almost simultaneously for
measurement of plasma concentrations of PGE2 and plasma
renin activity. Then aspirin was administered orally in the dose
of 20 mg/kg. Forty-five minutes later, a second blood sample
was taken at the same sites as before aspirin administration. All
blood samples were immediately placed in ice-cooled tubes
containing ethylenediaminetetraacetic acid 2 Na (1 mg/mI) and
aspirin (1 mg/mI) for assays of POE2 and renin activity. PGE2
was measured by radioimmunoassay after extraction and puri-
fication of the compound as described elsewhere [10, 13].
Plasma renin activity was measured by radioimmunoassay as
reported before [14].
The study was approved by the ethical review committee of
the National Cardiovascular Center. Informed consent was
obtained from the patients. None of the patients studied with
aspirin suffered any side effects.
Results
The times to the maximum peak of the renogram curve after
the intravenous injection of ['231]OIH are shown in Table 2. The
time to the peak was not different between the kidneys in
baseline or aspirin renography in patients 1 and 2 (controls), nor
was it different in captopnl renography in patient 2. In renovas-
cular hypertensive patients 3 to 6, who had moderate stenosis of
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Table 2. Time to the maximum peak of the renogram curves after the intravenous injection of iodine-l23-orthoiodohippurate
Patient
Baseline mm Aspirin mm Captopril mm
Right Left Right LeftRight Left
1 (non-RVH) 2.9 2.9 3.2 3.2 — —
Contra-
lateral Stenotic
Contra-
lateral Stenotic
Contra-
lateral Stenotic
2 (non-RVH)
3 (RVH)
4 (RVH)
5 (RVH)
6 (RVH)
7 (RVH)
8 (RVH)
9 (RVH)
3.3
3.3
3.4
2.4
2.7
3.2
4.3
2.9
3.5
4.5
4,8
3.1
3.1
5.2
6.3
9.5
4.9
3.8
3.3
3.3
2.9
5.5
7.8
5.7
4.9
6.7
7.3
9.4
5.9
13.4
>20
>20
4.4
3.3
7.1
—
2.9
4.1
—
6.3
4.5
6.6
—
4.7
6.6
—
>20
Columns headed Baseline, Aspirin, and Captopril show the time to the peak of the renogram curve of the baseline study, the study after aspirin
(20 mg/kg) administration, and the study after captopril (50 mg) administration, respectively. Abbreviations are: Right, right kidney; Left, left
kidney; Contralateral, the kidney without renal arterial stenosis; Stenotic, the kidney with renal arterial stenosis; non-RVH, patient without
renovascular hypertension; RVH, patient with renovascular hypertension.
a renal artery, the time to the peak in the stenotic kidney was
not significantly delayed in the baseline study, but it was
significantly delayed (more than 5 mm) by aspirin compared
with that in the contralateral kidney. However, captopril did
not significantly increase the difference between the kidneys. In
patient 4, in particular, captopril delayed the time to the peak
not only in the stenotic kidney but also in the contralateral one:
a difference between the kidneys was not seen. In patients 7 to
9, with renovascular hypertension and severe stenosis, the
baseline study showed significant delays in the time to the peak
of the stenotic kidney. Both aspirin and captopril delayed the
time in the two kidneys, but further increased the delay in the
stenotic kidney. When our definitions of "significant decrease"
and "difference" were used, aspirin increased the sensitivity of
detection of unilateral renovascular hypertension from 43% (3
of 7) with baseline renography to 100% (7 of 7).
Figure 1 shows representative time-activity curves of renog-
raphy of patient 2 (control), patient 4 (with moderate stenosis of
a renal artery), and patient 9 (with severe stenosis). For patient
2, there was no difference between the kidneys in the renograms
from the three tests. In patient 4, only aspirin renography
showed a difference between the stenotic kidney and the
contralateral kidney; in comparison with the baseline results,
the phases of concentration and excretion were delayed in the
stenotic kidney. This phenomenon could be observed in images
of sequential scintigraphy, without use of a computer to gener-
ate renogram curves (Fig. 2). In patient 9, with severe stenosis,
aspirin and captopril increased the differences between the
baseline renogram curves of the two kidneys (Fig. 1).
The systemic blood pressure had not changed significantly
one hour after the oral administration of aspirin in any patient
(Table 3). After the administration of captopril, blood pressure
decreased in patients 2, 4, and 6 (Table 3).
Levels of renin activity and PGE2 in aortic and renal venous
plasma are shown in Table 4. In patients with renovascular
hypertension, the levels of renin activity and PGE2 in renal
venous plasma from the stenotic kidney were higher than those
in the renal venous plasma from the contralateral kidney or in
the aortic plasma. In these patients, stenotic/normal-side ratios
of renin and PGE2 were more than 1.5, except for patient 3. In
patient 2, without renovascular hypertension, renin activity was
low at all sites sampled, and the PGE2 level was not higher in
renal venous plasma from the stenotic side. Forty-five minutes
after the oral administration of aspirin, the PGE2 levels in aortic
plasma and renal venous plasma from the stenotic and con-
tralateral sides had decreased in all patients whose blood was
sampled (data in parentheses in Table 4). Remn release from the
stenotic kidney was suppressed by aspirin in patients with
renovascular hypertension, but not in patient 2 (in parentheses
in Table 4).
Discussion
We suggest on the basis of results from these few subjects
that aspirin renography with ['231]OIH disclosed renovascular
hypertension with moderate stenosis of the renal artery not
detected by either baseline or captopril renography, and that
aspirin renography confirmed the diagnosis of renovascular
hypertension when stenosis was severe.
Administration of captopril before renography inhibits the
effects of angiotensin II, which helps to maintain the glomerular
filtration rate in the presence of renal arterial stenosis [1—4].
When captopril is used with mTcDTPA, renography seems to
give more sensitive and specific results than when captopnl is
used with ['231]OIH [2, 5, 15]. Two reasons may be that
renography with mTcDTPA reflects the glomerular filtration
rate but that renography with [1231]OIH reflects the renal blood
flow as well as glomerular filtration [2], and that a single oral
administration of captopril does not decrease the renal blood
flow, although the primary effect of captopril on the stenotic
kidney is to decrease the glomerular ifitration rate [16]. How-
ever, the best tracer for captopril renography is still not certain
[3, 17]. There is a report that the administration of furosemide
in addition makes diagnosis by captopril renography with
['231]OIH more sensitive than that with mTcDTPA [15, 18].
In our study, captopril renography with ['231]OIH did not
detect renovascular hypertension in patients 3, 4, and 6, with
moderate stenosis of a renal artery in which blood flow to the
stenotic kidney seemed not to have decreased. In patient 3,
renin release from the stenotic kidney was not great, and the
effect of angiotensin II on the glomerular filtration rate might
have been small. In patient 4, the time until the peak of the
renogram was delayed in the kidney without stenosis as well as
in that with stenosis; there was no difference between the two
kidneys. In other words, the results of the captopril renography
suggested bilateral renal arterial stenosis. The acute decrease in
blood pressure caused by captopril (Table 3) might have caused
this result, or the renin-angiotensin system might have hemo-
dynamic effects on the contralateral kidney. False-positive
results by captopril renography (suggesting bilateral renal arte-
rial stenosis) have been obtained for patients whose blood
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Fig. 1. Renogram curves of patient 2 (without renovascular hypertension) and of patients 4 and 9 (with renovascular hypertension). 2a—2c, patient
2; 4a—4c, patient 4, with moderate stenosis of a renal artery; 9a—9c, patient 9, with severe stenosis of a renal artery. Results from the baseline study
are shown in 2a, 4a, and 9a. 2b, 4b, and 9b are renograms taken one hour after the oral administration of aspirin (20 mg/kg). 2c, 4c, and 9c are
renograms taken one hour after the oral administration of captopril (50 mg). The ordinate and abscissa indicate radioactivity and time (kiloseconds),
respectively. Solid and dotted lines are renograms of the stenotic and contralateral kidneys, respectively. Abbreviation cts/sec is counts per
second.
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Fig. 2. Renal scinrigraphy of patient 4.
Selected images of sequential scintigraphy
done 2, 3, 5, and 8 mm after the intravenous
injection of ['231]OIH. Abbreviations are:
Control, baseline study; Aspirin, scintigraphy
done after administration of aspirin (20 mgI
kg); Captopril, scintigraphy done after
administration of captopril (50 mg); L, left
(stenotic) kidney; R, right (normal) kidney.
Table 3. Systemic blood pressure before and one hour after oral administration of aspirin or captopril
Patient
BP before and after aspirin 20 mg/kg BP before and after captopril 50 mg
Before mm Hg After mm HgBefore mm Hg After mm Hg
1 (non-RVH) 151 4/100 1 156 2/103 4 — —
2 (non-RVH) 126 4/88 2 136 3/93 2 139 4/81 1 123 3a/79 1
3(RVH) 134±3/85 135±3/86 151±3/97±2 147±4/94±1
4 (RVH) 158 3/97 1 153 4/91 3 162 3/87 2 140 l/72 3
5 (RVH) 176 3/97 2 171 9/93 3 — —
6 (RVH) 133 4/86 2 125 4/77 4 130 1/81 1 123 2a/72 3a
7(RVH) 152±1/80 150±4/79 140±3/76±1 136±2/74±1
8 (RVH) 190 3/121 1 177 11/1 18 2 — —
9 (RVH) 120 4/62 2 120 5/65 2 116 4/58 3 113 5/58 1
Systemic blood pressure (BP) is expressed as the mean systolic/diastolic pressure SEM (4 measurements, [mm HgJ/[mm Hg]). RVH is
renovascular hypertension.
a P < 0.05 compared with values before administration
pressure was much decreased by captopril or whose renin-
angiotensin system was activated by a low-sodium diet [19].
The blood pressure of our patient 2 was decreased by captopril,
but the decrease was slight and the basal plasma renin activity
was low; the results of captopril renography did not show
renovascular hypertension. In normotensive subjects or pa-
tients with essential hypertension, a single dose of captopril
either does not change or else slightly decreases the glomerular
filtration rate, according to a review of many reports [16].
However, the effect of captopril on glomerular filtration is not
specific [16], and may depend on the individual, on systemic
hemodynamic changes, and on sodium intake.
['231]OIH is filtered through the glomeruli and excreted from
the tubules, but 99mTc..DTpA is filtered only [2]. Thus,
['231]OIH is more readily excreted from the kidney and is
suitable for use as a tracer in the assessment of overall renal
function (renography is not only for screening for renovascular
hypertension). Now, ['231]OIH is much used in renography.
However, the radioactive half-life of [1231]OIH is longer than
that of mTcDTPA. Recently, 99mTc..mercaptoacetyltljgIy..
cine, which is filtered and excreted from the kidney, was
developed as a tracer to replace [1231]OIH [2, 3]. Its use in the
diagnosis of renovascular hypertension is being tested [3, 201.
The rationale for our study is that in the stenotic kidney in
unilateral renovascular hypertension, PG is increased, and
helps to maintain the blood flow and to stimulate the renin-
angiotensin system [7, 10]. Inhibition of PG synthesis decreases
the blood flow and glomerular filtration rate, and thus reduces
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Table 4. Plasma levels of renin activity and prostaglandin E2 in the aorta and renal veins before and after administration of aspirin
Plasma renin activity ng/mi/hr POE2 in plasma pg/mi
Contra- Contra-
Patient Aorta Stenotic lateral Aorta Stenotic lateral
2 (non-RVH) 0.5
(0.5)
0.6
(0.5)
0.6
(0.6)
2.1
(0.6)
2.3
(0.3)
2.4
(0.5)
3 (RVH) 2.1
(1.6)
2.5
(1.7)
2.0
(1.6)
1.1
(0.4)
3.0
(0.5)
2.2
(0.6)
4 (RVH) 3.9
(3.0)
6.5
(4.5)
4.3
(2.8)
0.7
(0.6)
12.0
(1.0)
3.0
(0.9)
7 (RVH) 7.1
(6.0)
14.5
(9.2)
7.4
(6.3)
2.9
(0.6)
6.8
(1.0)
3.1
(1.2)
8 (RVH) 14.8
(12.9)
48.6
(23.7)
19.3
(14.6)
4.2
(2.0)
23.7
(2.4)
14.0
(1.7)
9 (RVH) 1.3
(0.8)
3.3
(1.1)
1.3
(0.9)
3.5
(1.0)
8.8
(1.2)
4.7
(0.4)
Mean of 3, 5.8 2.4 15.1 8.6a 6.9 3.3 2.5 0.7 10.9 3•5a 5.4 2.2
4, and 7—9 (4.8 22)" (8.0 4.2)" (5.2 2.5)" (0.9 0.3)" (1.2 03)" (1.0 02)"
Data in parentheses show levels of renin activity or prostaglandin E2 at 45 mm after the oral administration of aspirin (20 mg/kg). Abbreviations
are: POE2, prostaglandin E2; RVH, renovascular hypertension; Stenotic, renal vein in the stenotic kidney; Contralateral, renal vein in the
contralateral kidney. Data are means 5EM of patients 3, 4, & 7 to 9 with RVH. The values in aortic and renal venous plasma were compared
by randomized block analysis of variance followed by Student-Newman-Keuls' test for simultaneous multiple comparison, with log conversion of
means SEM of plasma renin activity. Plasma renin activity and POE2 levels before and alter administration of aspirin were compared by Student's
paired t-test.
a P C 0.05 compared with values in aortic plasma and also in renal venous plasma in the contralateral side
"P C 0.05 compared with values before aspirin administration
urine flow rate in the stenotic kidney, as seen in our study of the
delayed phases of concentration and excretion of ['231]OIH in
not only patients 7 to 9 but also in patients 3 to 6. In patient 3
with renovascular hypertension, the stenotic/normal-side renin
ratio (<1.5) did not satisfy the diagnostic criteria for renovas-
cular hypertension. The degree of stenosis of the renal artery
was not severe and the increase in POE2 synthesis in the
stenotic kidney was not large compared with those in other
patients with renovascular hypertension. However, the inhibi-
tion of PG synthesis by aspirin made diagnosis possible from
the renogram taken with ['231]OIH.
Therefore, when [1231]OIH or mTcmercaptoacetyltrigly
cine is used as a tracer in renography, the PG synthesis inhibitor
aspirin may be more useful than captopril for detection of
stenosis that causes hypertension.
In patients 7 to 9, the time to the peak of the renogram of the
contralateral kidney was delayed to more than five minutes by
aspirin, as well as that of the stenotic kidney. The urine flow
rate during renography was not observed, but we believe that
the patients were adequately hydrated, because water intake
was not limited, sodium in the diet was not restricted to a low
level, and 250 ml of water was taken before the renography. The
duration of hypertension in patients 7 to 9 was much longer than
in the other patients, so microvascular damage of the non-
stenotic kidney is likely. Such damage could help to explain the
delay in the peak time via the inhibition of PG and the decrease
in renin release caused by aspirin. However, the changes
caused by aspirin in the renogram curve of the stenotic kidney
were larger than those in the nonstenotic kidney, so diagnosis
was possible.
An oral dose of 20 mg/kg aspirin should be enough to inhibit
renal synthesis of PGs by one hour alter administration, be-
cause this dose markedly decreased POE2 levels in the renal
venous plasma from the stenotic and contralateral sides 45
minutes alter the administration. The inhibitory effect of a
single dose of aspirin (20 mg/kg) seems to be reversible and to
cause little damage to the kidneys, because the patients studied
did not show any side effects. However, that nonsteroidal
antiinflammatory drugs such as aspirin can cause kidney dam-
age should be kept in mind.
Intravenous administration of aspirin DL-lysine lowers blood
pressure (at 30 mm there is a small but significant decrease) in
patients with unilateral renovascular hypertension [10], but oral
administration of aspirin did not significantly lower blood
pressure (1 hr later) in the study reported here. The different
results may have arisen as follows. First, in the earlier report
[10], we compared the means of blood pressure of six patients
before and alter aspirin, but here, we compared the means of
each patient's data before and alter treatment. Second, the
baseline blood pressure before aspirin administration was al-
ready lowered by antihypertensive drugs. Third, in patient 9,
the release of renin might have been suppressed by a 13-blocker.
Fourth, the routes for the administration of aspirin were differ-
ent (intravenous or oral); the effect of aspirin on blood pressure
was acute or not. Having little effect on blood pressure is a
desirable characteristic for drugs to be used for renography;
aspirin has this characteristic, but captopril does not.
Here, the patients with renovascular hypertension were
taking antihypertensive drugs. A Ca2-antago&st, nifedipine or
nilvadipine, was being given to all of these patients. Prostanoid
synthesis is increased via phospholipase A2 activated by Ca2,
so such synthesis may be inhibited by Ca2-antagonists [21].
However, POE2 levels in the renal venous plasma in the
stenotic kidney of the patients were not decreased but in-
creased, and the results of aspirin renography were as ex-
pected. In patient 9 with renovascular hypertension, plasma
renin activity was low, probably because of atenolol adminis-
tration. However, this study showed that the effects of in-
creased PG on renin release and renal hemodynamics in the
stenotic kidney might not have been influenced by atenolol or
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the other drugs being taken. Several investigators have reported
that the /3-adrenergic mechanism of renin release is independent
of the PG system [22, 23]. These results indicate that aspirin
renography can be done without discontinuation of the antihy-
pertensive drugs being taken (the two Ca2tantagonists,
atenolol, and guanabenz) except for those that inhibit PG
production. Captopril renography with mTcDTPA also can
be done without discontinuation of antihypertensive drugs with
the exception of angiotensin converting enzyme inhibitors (the
test depends on the response to acute inhibition of the convert-
ing enzyme) [3]. However, Ca2-antagonists can selectively
influence the afferent arteriolar response to angiotensin II [24],
and this effect may account for the decrease in the sensitivity of
captopril renography done with [1231]OIH, but not that done
with 99mTC..DTPA. We have reported that increased synthesis
of PGE2 in response to renal arterial stenosis is not mediated by
angiotensin II in anesthetized dogs [25]. It may not be necessary
to discontinue inhibitors of angiotensin converting enzyme
before aspirin renography.
We have chosen to use the difference in peak activity
between the stenotic and the contralateral sides as one criterion
for the presence of renovascular hypertension. Other criteria in
the renography, a semiquantitative method, has been described
by others [18]. It has not been established which method is
specific and superior, and we have chosen to use the difference
in peak times in renograms, which is easily measured, in this
proposal of a method to detect unilateral renovascular hyper-
tension.
In conclusion, radionuclide renography (with [1231]OIH) done
alter the administration of aspirin should make possible sensi-
tive detection and diagnosis of unilateral renovascular hyper-
tension.
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